Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Intrathecal Compounding Specialists, LLC
483
•Intrathecal Compounding Specialists, LLC•November 17, 2017

Intrathecal Compounding Specialists, LLC – FDA 483, Nov 17, 2017

Record Details

During an FDA inspection, several deficiencies were noted regarding aseptic processing and quality control. The facility failed to adequately evaluate and take remedial action for actionable microbial contamination in the ISO 5 aseptic processing area, specifically when employee fingertip tests repeatedly yielded positive results without microorganism identification, yet sterile drug production and distribution continued. Highly potent drugs were produced without adequate segregation, work surface cleaning, or personnel cleaning to prevent cross-contamination.

Personnel exhibited poor aseptic technique, touching non-ISO 5 surfaces with gloved hands before engaging in aseptic processing without glove changes or sanitization. Improper gowning was observed, including an employee touching the outside of gloves with a bare hand without disinfection before compounding sterile drugs. Exposed hair and mouth were noted in the ISO 5 environment during aseptic operations. Personnel reused fluid-resistant gowns throughout the day, leaving and re-entering cleanrooms from non-classified areas without replacing gowning apparel.

Supplies, materials, and equipment were not disinfected prior to entering ISO 5 and ISO 7 environments. Non-microbial contamination, specifically a brown-stained HEPA filter, was observed in the production area. The ISO 5 area contained difficult-to-clean and particle-generating equipment, evidenced by threads stuck in a laminar flow hood outlet cover. Disinfectant contact times and coverage were insufficient, with employees observed cleaning front to back, reusing wipes, and cleaning during operations with the same portion of a wipe.

ISO-5 classified areas were not certified under

Company
Intrathecal Compounding Specialists, LLC
Inspection date
November 17, 2017
Product type
Drugs
Office
New Orleans District Office
Person
  • Claire M. Minden (CO CDER OMQ)
View Company Profile

ID · 43e1e50d-a604-4d68-8f78-f9e0d376ac05

Violation Codes3
21 CFR 21021 CFR 211FD&C Act 801(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Intrathecal Compounding Specialists, LLC
  • 483 - 2021-08-19August 19, 2021
  • 483 - 2019-02-14February 14, 2019
  • 483_RESPONSE - 2017-11-17November 17, 2017
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Intrathecal Compounding Specialists, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.